Litcius/Paper detail

Nivolumab plus ipilimumab in melanoma brain metastases

Alessandro Rizzo

2022The Lancet Oncology13 citationsDOI

Topics & Concepts

MedicineIpilimumabNivolumabMelanomaOncologyInternal medicineMetastatic melanomaClinical endpointOverall survivalPhases of clinical researchClinical trialImmunotherapyBrain metastasisStage (stratigraphy)DiseaseCancerAdverse effectBrain Metastases and TreatmentCancer Immunotherapy and BiomarkersMelanoma and MAPK Pathways